• Blog Post

Genoa Healthcare’s Behavioral Health Services Featured in Chain Drug Review

May 17th, 2022

As demand for behavioral health care continues to rise amid soaring rates of mental illness and substance use disorder, Genoa Healthcare® is helping bridge the gap in care for underserved populations. Genoa’s approach to pharmacy services was recently featured in Chain Drug Review.

The article highlights Genoa’s commitment to providing compassionate care to consumers and working with partners to serve communities through every phase of the pandemic.

“The need for access to quality pharmacy care is greater than ever,” said Genoa Healthcare Chief Executive Officer Joe Douglas. “The pandemic continues to affect those with complex, chronic conditions disproportionately. Our location in the community puts us in a position to fill the gaps in care that have been brought into sharp focus this year.”

You can read the full article here or view it in Chain Drug Review’s recent issue.

Recent Posts


  • Pharmacy Openings
Announcing six new pharmacy openings!

We’re excited to announce the opening of six pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Pharmacy Openings
Announcing seven new pharmacy openings!

We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve their...

  • Blog Post
Genoa Healthcare® Pharmacists’ Trusting Consumer Relationships Aid in Support for Long-Acting Injectable Treatments

Providing Support for Long-Acting Injectable Treatments When a consumer who had recently been discharged from the hospital came into their Genoa pharmacy to receive a long-acting injectable (LAI) treatment for...

  • News Releases
New medication options in behavioral health

FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...